Pitchbook says private equity investments are shifting. Here's how the landscape is changing and what it means for investors.

Pitchbook says private equity investments are shifting. Here's how the landscape is changing and what it means for investors.

Private equity firms are showing more interest in new care models in the healthcare industry. With challenges such as staff shortages, high expenses, and low reimbursement rates, healthcare providers are struggling. Private equity firms see an opportunity in areas such as healthcare IT, pharmaceuticals, and multispecialty providers. These new care models offer potential for growth and innovation.

The rising popularity of weight loss drugs like Novo Nordisk's Wegovy and Ozempic is also impacting private equity investments. More patients are demanding these medications, leading to an increase in telehealth platforms prescribing them. While there are potential health benefits, clinicians are concerned about the short-term effects on patients. Additionally, increased use of these drugs could decrease procedure volumes in bariatric surgery, cardiovascular care, and orthopedics, affecting the returns on private equity investments.

Investors were once focused on out-of-network and cash-pay providers to maximize profits. However, industry changes such as the No Surprises Act have forced investors to reconsider. This legislation prohibits unexpected out-of-network bills for patients treated in an in-network facility. Private equity-backed staffing companies have already collapsed due to the law, leading to financial repercussions. Envision Healthcare, backed by private equity firm KKR, filed for Chapter 11 bankruptcy protection, citing lost revenue.

Multispecialty groups have become hot targets for private equity investments. As cost pressures persist and more care shifts to the outpatient setting, investors are looking for opportunities in multispecialty groups. These groups are catching the eye of mega-retailers like CVS and Walgreens. Additionally, investors are showing interest in specialized care, including cardiology, neurology, and radiology.

Value-based care is another area where private equity firms are looking to invest. Payers and providers are recognizing the potential of value-based care in lowering healthcare costs. As the industry shifts towards this model, private equity firms are more inclined to invest in operations that promote cost-saving measures. Primary care and multispecialty practices are examples of entities that can fall into this category.

Despite the challenges posed by the pandemic, the U.S. economy has shown resilience. Employers have added 3.1 million jobs over the past 12 months, and the unemployment rate rose slightly as more Americans joined the workforce. The government's injection of cash and low interest rates have supported businesses and consumers, enabling them to lock in lower borrowing costs. Additional legislation has further boosted federal spending and private-sector investment in manufacturing.

Companies are holding onto workers and increasing pay, leading to real after-tax income growth. This strong income growth is bolstering the backbone of the U.S. economy. The Federal Reserve has taken measures to slow credit-sensitive activity, but the overall strength of the economy remains intact.

The recovery from the pandemic has been uneven across industries. Some sectors that are typically sensitive to interest rates, such as auto production, have been less affected this year. Federal funding from infrastructure packages and legislation supporting renewable energy production and semiconductor manufacturing continues to support economic growth.

Overall, the private equity investment landscape is shifting towards new care models, multispecialty groups, and value-based care in the healthcare industry. Investors must adapt to these changes and consider the potential impact of rising interest in weight loss drugs and the decrease in out-of-network providers. As the U.S. economy proves resilient, private equity firms can find opportunities for growth and innovation.

Actionable Advice:

1. Stay updated on industry changes: Keep track of new legislation and regulations that can impact private equity investments in healthcare. Be aware of the potential risks and opportunities presented by these changes.
2. Diversify your portfolio: As the private equity landscape shifts, consider diversifying your investments across different sectors and areas of healthcare. This can help mitigate risks and maximize potential returns.
3. Focus on value-based care: Invest in operations and practices that promote value-based care and cost-saving measures. Look for opportunities in primary care and multispecialty practices that align with the shift towards value-based reimbursement models.

In conclusion, private equity investments in healthcare are evolving. The focus is shifting towards new care models, multispecialty groups, and value-based care. Investors must navigate the changing landscape and adapt their strategies to maximize returns. By staying informed, diversifying their portfolios, and focusing on value-based care, investors can position themselves for success in this shifting market.